U.S. Markets closed
LISTEN

Schultz: Businesses need to do more to help people

Yahoo Finance's Julia La Roche sits down with executive chairman and former CEO of Starbucks Howard Schultz

Laboratorios Farmaceuticos ROVI, S.A. (ROVI.MC)

MCE - MCE Delayed Price. Currency in EUR
Add to watchlist
16.000.00 (0.00%)
At close: 5:35PM CEST
Full screen
Previous Close16.00
Open15.72
Bid15.72 x 8400
Ask16.50 x 15000
Day's Range15.72 - 15.72
52 Week Range10.80 - 18.75
Volume13
Avg. Volume3,509
Market Cap789.07M
BetaN/A
PE Ratio (TTM)33.06
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Laboratorios Farmaceúticos Rovi SA : Overvalued relative to peers, but may deserve another look
    Capital Cube5 months ago

    Laboratorios Farmaceúticos Rovi SA : Overvalued relative to peers, but may deserve another look

    Categories: Yahoo FinanceLaboratorios Farmaceúticos Rovi SA relative valuation is now OVERVALUED. It was previously rated UNDERVALUED, and has a fundamental analysis score of 78. Our analysis is based on comparing Laboratorios Farmaceúticos Rovi SA with the following peers – Almirall SA, Lavipharm S.A., Bioorganic Research & Services SA and Recordati S.p.A. (ALM-ES, LAVI-GR, BNT-ES and REC-IT). Relative ... Read more (Read more...)

  • Laboratorios Farmaceúticos Rovi SA : A good buy now? Relative to peers, maybe.
    Capital Cube7 months ago

    Laboratorios Farmaceúticos Rovi SA : A good buy now? Relative to peers, maybe.

    Categories: Yahoo Finance Laboratorios Farmaceúticos Rovi SA relative valuation is now UNDERVALUED. It was previously rated OVERVALUED, and has a fundamental analysis score of 72. Our analysis is based on comparing Laboratorios Farmaceúticos Rovi SA with the following peers – Almirall SA, Lavipharm S.A., Bioorganic Research & Services SA and Recordati S.p.A. (ALM-ES, LAVI-GR, BNT-ES and REC-IT). Relative ... Read more (Read more...)

  • Laboratorios Farmaceúticos Rovi SA : Fairly valued, but don’t skip the other factors
    Capital Cubelast year

    Laboratorios Farmaceúticos Rovi SA : Fairly valued, but don’t skip the other factors

    Categories: Yahoo Finance Laboratorios Farmaceúticos Rovi SA relative valuation is now NEUTRAL. It was previously rated OVERVALUED, and has a fundamental analysis score of 50. Our analysis is based on comparing Laboratorios Farmaceúticos Rovi SA with the following peers – Almirall SA, Lavipharm S.A., Bioorganic Research & Services SA and Recordati S.p.A. (ALM-ES, LAVI-GR, BNT-ES and REC-IT). Relative ... Read more (Read more...)